← Leaderboards
T. Jake Liang
National Institute Of Diabetes And Digestive And Kidney Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Diabetes And Digestive And Kidney Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsInfectionViralHepatocyteIn VivoHepatitis CGenesVirus ReplicationHepatitis C VirusBaseAntiviral AgentsResponseLiverVirusProteinsIn VitroVirus DiseasesBiological ModelsMediatingLiver DiseasesAffectComplexGene Expression
Grant awards (62)
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases$2,150,109
ZIA · FY2025 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,881,345
ZIA · FY2025 · DK · contact PI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases$1,343,818
ZIA · FY2025 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$2,126,338
ZIA · FY2024 · DK · contact PI
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases$2,063,799
ZIA · FY2024 · DK · contact PI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases$2,063,799
ZIA · FY2024 · DK · contact PI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases$2,198,134
ZIA · FY2023 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$2,014,956
ZIA · FY2023 · DK · contact PI
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases$1,709,660
ZIA · FY2023 · DK · contact PI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases$1,991,797
ZIA · FY2022 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,707,254
ZIA · FY2022 · DK · contact PI
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases$1,422,712
ZIA · FY2022 · DK · contact PI
Studies of HCV Infection, Vaccine Development and HCV-Host interactions$569,085
ZIA · FY2022 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis and Other Viral Diseases$1,696,123
ZIA · FY2021 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,453,819
ZIA · FY2021 · DK · contact PI
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases$969,213
ZIA · FY2021 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$726,910
ZIA · FY2021 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis and Other Viral Diseases$1,512,099
ZIA · FY2020 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,512,099
ZIA · FY2020 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$1,008,066
ZIA · FY2020 · DK · contact PI
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases$1,008,066
ZIA · FY2020 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,745,409
ZIA · FY2019 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$1,246,721
ZIA · FY2019 · DK · contact PI
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases$997,377
ZIA · FY2019 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis$997,377
ZIA · FY2019 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,569,787
ZIA · FY2018 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$1,121,276
ZIA · FY2018 · DK · contact PI
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases$897,021
ZIA · FY2018 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C$897,021
ZIA · FY2018 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence$1,269,873
ZIA · FY2017 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C$1,058,228
ZIA · FY2017 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$1,058,228
ZIA · FY2017 · DK · contact PI
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases$634,937
ZIA · FY2017 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$211,646
ZIA · FY2017 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$883,795
ZIA · FY2014 · DK · contact PI
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases$707,036
ZIA · FY2014 · DK · contact PI
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C$707,036
ZIA · FY2014 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence$707,036
ZIA · FY2014 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$530,277
ZIA · FY2014 · DK · contact PI
Mechanisms of Interferon-based Therapy and Resistance in HCV Infection$830,823
ZIA · FY2012 · DK · contact PI
Studies of HCV Infection And HCV-Host interactions$830,823
ZIA · FY2012 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence$664,658
ZIA · FY2012 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$664,658
ZIA · FY2012 · DK · contact PI
Molecular Approaches To Vaccine Development For Hepatitis C$332,329
ZIA · FY2012 · DK · contact PI
Cell Culture And Animal Models of HCV Infection And HCV-Host interactions$529,325
ZIA · FY2011 · DK · contact PI
Mechanisms of Interferon-based Therapy and Resistance in HCV Infection$504,325
ZIA · FY2011 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence$378,243
ZIA · FY2011 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$378,243
ZIA · FY2011 · DK · contact PI
Molecular Approaches To Vaccine Development For Hepatitis C$378,243
ZIA · FY2011 · DK · contact PI
Cell Culture And Animal Models of HCV Infection And HCV-Host interactions$519,744
ZIA · FY2010 · DK · contact PI
Mechanisms of Interferon-based Therapy and Resistance in HCV Infection$519,744
ZIA · FY2010 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$389,808
ZIA · FY2010 · DK · contact PI
Molecular Approaches To Vaccine Development For Hepatitis C$389,808
ZIA · FY2010 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence$389,808
ZIA · FY2010 · DK · contact PI
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy$389,808
ZIA · FY2010 · DK · contact PI
Mechanisms of Interferon-based Therapy and Resistance in HCV Infection$644,507
ZIA · FY2009 · DK · contact PI
Molecular Approaches To Vaccine Development For Hepatitis C$644,507
ZIA · FY2009 · DK · contact PI
Cell Culture And Animal Models of HCV Infection And HCV-Host interactions$644,507
ZIA · FY2009 · DK · contact PI
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy$483,380
ZIA · FY2009 · DK · contact PI
The Genetics of Disease Progression and Treatment Response in Hepatitis C$483,380
ZIA · FY2009 · DK · contact PI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence$322,253
ZIA · FY2009 · DK · contact PI
Nonalcoholic Steatohepatitis: Natural History and Therapy$466,145
Z01 · FY2008 · DK · contact PI